PHI with Chronic Active Hepatitis
How does this condition affect your private health insurance?
Chronic active hepatitis (CAH) refers to a persistent inflammation of the liver lasting for more than six months. It's characterized by ongoing liver cell necrosis and inflammation, often leading to fibrosis and cirrhosis. Causes include chronic viral infections (Hepatitis B, C), autoimmune disorders, and certain drug reactions. Symptoms can vary from fatigue and jaundice to more severe signs of liver failure. Untreated, it can progress to end-stage liver disease, liver cancer, and death. Diagnosis involves blood tests, imaging, and liver biopsy. Treatment aims to suppress the inflammation, prevent progression, and manage complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months, sometimes with an acute onset over days.
Duration of Illness (Lifetime)
Lifelong, chronic disease if not successfully treated or eradicated.
Cost of Treatment (Initial)
High (e.g., several thousand to tens of thousands of USD for initial diagnosis and stabilization).
Cost of Treatment (Lifetime)
Very high (e.g., tens of thousands to hundreds of thousands of USD, potentially over a million with liver transplant and lifelong management).
Mortality Rate
Significant if untreated or if cirrhosis/liver cancer develops (e.g., 5-20% over 10 years, higher with advanced disease and complications).
Risk of Secondary Damages
High (cirrhosis, liver failure, hepatocellular carcinoma, portal hypertension, variceal bleeding, ascites, hepatic encephalopathy; also significant psychological impact due to chronic illness).
Probability of Full Recovery
Variable. For some viral causes (e.g., Hepatitis C), high with modern antiviral treatments. For autoimmune or chronic Hepatitis B, complete cure is rare, but sustained remission and disease control are achievable.
Underlying Disease Risk
Moderate to high, depending on the etiology (e.g., other autoimmune diseases for autoimmune hepatitis, co-infections like HIV for viral hepatitis).